Shopping Cart
- Remove All
Your shopping cart is currently empty
IL-33 Protein, Human, Recombinant V2 is expressed in E. coli. The accession number is O95760.

| Pack Size | Price | Availability | Quantity |
|---|
| Biological Activity | ED 50 < 0.5 ng/ml, measured by a cell proliferation assay using D10S cells, corresponding to a specific activity of > 2.0 × 10^6 units/mg. |
| Description | IL-33 Protein, Human, Recombinant V2 is expressed in E. coli. The accession number is O95760. |
| Species | Human |
| Expression System | E. coli |
| Tag | Tag Free |
| Accession Number | O95760 |
| Synonyms | NF-HEV,NFEHEV,interleukin 33,IL1F11,DVS27,C9orf26 |
| Construction | Ser112-Thr270 |
| Protein Purity | > 95% as determined by SDS-PAGE |
| Molecular Weight | 18.0 kDa (Reducing conditions) |
| Endotoxin | < 0.2 EU/μg of the protein as determined by the LAL method. |
| Formulation | Lyophilized from 0.22 μm filtered solution in PBS. |
| Stability & Storage | Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
| Shipping | In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice. |
| Research Background | Interleukin-33 (IL-33) is a proinflammatory cytokine that belongs to the IL-1 family. IL-33 is expressed in a variety of cells, including epithelial and endothelial cells, smooth muscle cells, macrophages and fibroblasts. The primary receptors for IL-33 are ST2 and IL-1 receptor accessory protein (IL-1RAcP), both of which belong to the IL-1 receptor family. IL-33 is localized to the nucleus of resting cells where it binds to chromatin in the H2A-H2B histone complex as a transcriptional suppressor. IL-33 is secreted by cells during injury which induces a T-helper 2 type inflammatory response. Evidence suggests IL-33 plays a role in autoimmune disease. IL-33’s interaction with ST2 can drive allergic pathology and IL-33 has been reported to play a role in the development of rheumatoid arthritis and systemic lupus erythematosus. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.